On-Demand Webinars
-
Building Scalable Non-Viral Gene-Edited Cell Therapy Processes
6/24/2026
Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.
- Automating cell therapy manufacturing without redesigning established workflow 6/24/2026
-
Automating Cell Therapy Manufacturing Without Redesigning Workflows
6/23/2026
Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.
-
How Intensified Upstream Processing Improves Scale-Up And Tech Transfer
6/22/2026
Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.
-
Generate Stable High-Producing Clones In 14 Weeks
6/18/2026
Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.
-
Creative Chromatography Solutions For Complex Small Molecules
6/18/2026
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
Elevate Your Protein Production With SynWeave™
6/15/2026
Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.
-
Enabling Clinical-Grade Automated Manufacturing Of γδ T Cells
6/12/2026
Explore smarter approaches to γδ T cell manufacturing, including scalable expansion, efficient transduction, and streamlined analytics, as well as how to build workflows that support validation.
-
Establishing The First Chinese Haplobank Of Clinical-Grade hiPSCs
6/11/2026
Learn how automated, closed workflows and GMP-ready infrastructure are advancing pluripotent stem cell development from scalable expansion and differentiation to building regional capacity.
-
Achieving Clinical Quality For Human iPSC Generation And Expansion
6/11/2026
Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.